Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025)
Praxis Precision Medicines (PRAX) has 3 years of Return on Sales data on record, last reported at 39.28% in Q3 2025.
- For Q3 2025, Return on Sales rose 14892.0% year-over-year to 39.28%; the TTM value through Sep 2025 reached 39.28%, up 6291.0%, while the annual FY2024 figure was 23.4%, 2824.0% up from the prior year.
- Return on Sales reached 39.28% in Q3 2025 per PRAX's latest filing, down from 34.98% in the prior quarter.
- Across five years, Return on Sales topped out at 8.57% in Q4 2024 and bottomed at 188.2% in Q3 2024.
- Average Return on Sales over 3 years is 64.63%, with a median of 53.99% recorded in 2023.
- Peak YoY movement for Return on Sales: plummeted -13367bps in 2024, then soared 14892bps in 2025.
- A 3-year view of Return on Sales shows it stood at 53.99% in 2023, then surged by 84bps to 8.57% in 2024, then crashed by -358bps to 39.28% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Sales were 39.28% in Q3 2025, 34.98% in Q2 2025, and 28.69% in Q1 2025.